FDA Moves To Require Premarket Approval For Vaginal Mesh
The U.S. Food and Drug Administration on Tuesday issued two proposed orders that would reclassify surgical mesh for transvaginal repair of pelvic organ prolapse as a high-risk device and would require...To view the full article, register now.
Already a subscriber? Click here to view full article